Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c2689 |
|---|---|
| Identifier | NCT03105102 |
| Trial Title | A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Placebo for Risankizumab SC|DRUG: Risankizumab IV|DRUG: Placebo for Risankizumab IV|DRUG: Risankizumab SC|DRUG: Risankizumab On-Body Injector (OBI) |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Mesa |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2018-04-09 |
|---|---|
| Primary Completion Date | 2026-05 |
| Completion Date | 2026-05 |